Regulatory Effects of Combined Application of Estradiol Valerate and Letrozole on Serum Hormone Levels in Patients with Anovulatory Infertility
Abstract
This article reviews the pathogenic mechanisms of anovulatory infertility, focusing on the pharmacological characteristics of estradiol valerate and letrozole and their combined regulatory effects on serum hormone levels. Studies have shown that this combination therapy
can effectively regulate FSH, LH, estradiol, and progesterone levels, optimize follicular development, improve endometrial conditions,
thereby increasing the success rate of ovulation induction and pregnancy chances. This treatment strategy provides a new clinical intervention
option for patients with anovulatory infertility.
can effectively regulate FSH, LH, estradiol, and progesterone levels, optimize follicular development, improve endometrial conditions,
thereby increasing the success rate of ovulation induction and pregnancy chances. This treatment strategy provides a new clinical intervention
option for patients with anovulatory infertility.
Keywords
Anovulatory infertility; Estradiol valerate; Letrozole; Hormone regulation
Full Text:
PDFReferences
[1] Dong Xiaorui. Observation on the application of estradiol valerate combined with letrozole and progesterone in infertile patients with
polycystic ovary syndrome [J]. Drug Evaluation, 2021, 18(7): 441-443.
[2] Fu Difang, Li Xinwei, Wang Tingting, et al. Effects of estradiol valerate tablets combined with letrozole on the treatment of ovulatory
dysfunction infertility and its influence on follicular development and ovulation [J]. Chinese Journal of Human Sexuality, 2023, 32(2):
105-109.
[3] Li Jiheng, Guan Kuihua, Li Yangyang, et al. Clinical study on the combined treatment of estradiol valerate, letrozole and progesterone
in infertile patients with polycystic ovary syndrome [J]. Chinese Journal of Medicine, 2022, 12(1): 86-88.
DOI: http://dx.doi.org/10.70711/pmr.v2i3.5478
Refbacks
- There are currently no refbacks.
